HCMV infections after hematopoietic stem cell transplantation – diagnostic methods and importance of viral DNA level monitoring
HCMV infection is very common. The virus infects 30-90% of population. In immunocompromised patients effective elimination of the virus by immune system is limited by immunosuppressive therapy. Active hCMV infection after HSCT can lead to severe posttransplant complications, graft failure or even de...
Main Authors: | Joanna Bocian, Danuta Januszkiewicz-Lewandowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2015-02-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://phmd.pl/gicid/01.3001.0009.6498 |
Similar Items
-
Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01) -
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
by: Léna Royston, et al.
Published: (2021-04-01) -
Comparison of HCMV DNA load and antigenemia results in hematopoietic transplant recipients based on GVHD grade
by: Pajand O, et al.
Published: (2007-05-01) -
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
by: Léna Royston, et al.
Published: (2021-09-01) -
Cytomegalovirus Infection in Kidney Transplant Recipients
by: Dino Šisl, et al.
Published: (2021-04-01)